Tag

The panel will discuss ESG shareholder activism and corporate business strategies, programs and policies, as related to raising capital, M&A and profitability, board and C-level engagement, internal control, disclosure and corporate governance required to address known and...

The panel will address the rationale, planning and structuring of a going private transaction, including transaction structures, securities regulations, disclosure and filing requirements, timelines and litigation mitigation strategies.

Geopolitical and macroeconomic headwinds, such as rising interest rates, inflation, supply chain issues, scaling back of government stimulus and lower consumer demand, are likely to lead to great bankruptcy and restructuring activity for 2023 and beyond. The panel with discuss...

After a brief slowdown in 2021, shareholder activism has made a strong resurgence in 2022-23, with many new players and increased investments opportunities driven by depressed equity values. The panel will discuss the regulatory environment, SEC rules and regulations, universal...

The panel will discuss options available to companies and creditors in cannabis related insolvencies, including strategies under State and Federal law, receiverships, assignments for the benefit of creditors, other alternatives and latest case law.

As the healthcare industry is undergoing digital transformation, healthcare providers need to prioritize data analytics and technology imperatives to drive profitability and attract investment capital.  The panel will discuss key technology drivers in healthcare, performance...

Healthcare industry’s post-pandemic resilience and scale continue to attract capital and drive consolidation.  The panel will discuss transactional drivers and headwinds, such as supply chain disruptions and increasing labor costs, financing challenges, systemic distress and...

The panel will focus on current regulatory and compliance issues in the Cannabis industry domestically and internationally and their effect on corporate valuations, due diligence, capital investment activity and mergers and acquisitions. Speakers will also address industry...

Maturing cannabis industry is projected to reach sales of $70 billion by 2028 (Bloomberg).  The panel will discuss industry growth drivers, consolidation trends, restructuring alternatives, risk management, role of IP, access to capital, cross-border activity, valuations and...